GCG and hydrops fetalis: The general finding from Medline, Embase, and Pubmed was that the papers that were found to mention GLP-1 agonists in HF, generally only detailed their pharmacology and suggested their potential for therapeutic benefit with very few containing any experimental evidence for the application of these agents [10–23].